Global Pain Management Drugs Market Research Report 2017

1 Pain Management Drugs Market Overview 1

1.1 Pain Management Drugs Product Overview 1

1.2 Pain Management Drugs Segment by Types (Product Category) 2

1.2.1 Global Pain Management Drugs Revenue Comparison by Types 2

1.2.2 Opioids 3

1.2.3 NSAIDs 4

1.3 Global Pain Management Drugs Segment by Applications 4

1.3.1 Global Pain Management Drugs Revenue Comparison by Applications 4

1.3.2 Hospitals 5

1.3.3 Drugstores 6

1.3.4 Clinic 6

1.4 Global Pain Management Drugs Market by Regions (2012-2022) 7

1.4.1 Global Pain Management Drugs Market Size and Growth Rate Comparison by Regions (2012-2022) 7

1.4.2 North America Pain Management Drugs Status and Prospect (2012-2022) 8

1.4.3 Europe Pain Management Drugs Status and Prospect (2012-2022) 9

1.4.4 Asia-Pacific Pain Management Drugs Status and Prospect (2012-2022) 10

1.4.5 South America Pain Management Drugs Status and Prospect (2012-2022) 11

1.4.6 Middle East and Africa Pain Management Drugs Status and Prospect (2012-2022) 12

1.5 Global Pain Management Drugs Market Size (2012-2022) 13

2 Global Pain Management Drugs Market Competition by Manufacturers 14

2.1 Global Pain Management Drugs Revenue and Share by Manufacturers (2016 and 2017) 14

2.2 Manufacturers Pain Management Drugs Headquarters, Established Date, Product Types 17

2.3 Pain Management Drugs Market Competitive Situation and Trends 19

2.3.1 Pain Management Drugs Market Concentration Rate 19

2.3.2 Pain Management Drugs Market Share of Top 3 and Top 5 Manufacturers 20

2.3.3 Mergers & Acquisitions, Expansion 21

3 Global Pain Management Drugs Revenue by Regions (2012-2017) 27

3.1 Global Pain Management Drugs Revenue and Market Share by Regions (2012-2017) 27

3.2 North America Pain Management Drugs Revenue (2012-2017) 30

3.2.1 North America Pain Management Drugs Revenue and Growth Rate (2012-2017) 30

3.2.2 North America Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 30

3.3 Europe Pain Management Drugs Revenue (2012-2017) 31

3.3.1 Europe Pain Management Drugs Revenue and Growth Rate (2012-2017) 31

3.3.2 Europe Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 31

3.4 Asia-Pacific Pain Management Drugs Revenue (2012-2017) 32

3.4.1 Asia-Pacific Pain Management Drugs Revenue and Growth Rate (2012-2017) 32

3.4.2 Asia-Pacific Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 32

3.5 South America Pain Management Drugs Revenue (2012-2017) 33

3.5.1 South America Pain Management Drugs Revenue and Growth Rate (2012-2017) 33

3.5.2 South America Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 33

3.6 Middle East and Africa Pain Management Drugs Revenue (2012-2017) 34

3.6.1 Middle East and Africa Pain Management Drugs Revenue and Growth Rate (2012-2017) 34

3.6.2 Middle East and Africa Pain Management Drugs Revenue, Cost, Gross and Gross Margin (2012-2017) 34

4 Global Pain Management Drugs Consumption by Regions (2012-2017) 35

4.1 Global Pain Management Drugs Consumption by Regions (2012-2017) 35

4.2 North America Pain Management Drugs Consumption (2012-2017) 38

4.3 Europe Pain Management Drugs Consumption (2012-2017) 39

4.4 Asia-Pacific Pain Management Drugs Consumption (2012-2017) 40

4.5 South America Pain Management Drugs Consumption (2012-2017) 41

4.6 Middle East and Africa Pain Management Drugs Consumption (2012-2017) 42

5 Global Pain Management Drugs Market Analysis by Types 43

5.1 Global Pain Management Drugs Revenue and Market Share by Types (2012-2017) 43

5.2 Global Pain Management Drugs Revenue Growth Rate by Types (2012-2017) 45

6 Global Pain Management Drugs Market Analysis by Applications 46

6.1 Global Pain Management Drugs Consumption and Market Share by Applications (2012-2017) 46

6.2 Global Pain Management Drugs Consumption Growth Rate by Applications (2012-2017) 49

7 Analysis of Pain Management Drugs Industry Key Manufacturers 50

7.1 Pfizer 50

7.1.1 Company Profile 50

7.1.2 Product Information 51

7.1.3 Revenue, Cost, Gross and Gross Margin 51

7.2 GSK 52

7.2.1 Company Profile 52

7.2.2 Product Information 53

7.2.3 Revenue, Cost, Gross and Gross Margin 54

7.3 Grunenthal 54

7.3.1 Company Profile 54

7.3.2 Product Information 55

7.3.3 Revenue, Cost, Gross and Gross Margin 55

7.4 Bayer 56

7.4.1 Company Profile 56

7.4.2 Product Information 57

7.4.3 Revenue, Cost, Gross and Gross Margin 57

7.5 Sanofi 58

7.5.1 Company Profile 58

7.5.2 Product Information 59

7.5.3 Revenue, Cost, Gross and Gross Margin 59

7.6 Eli Lilly 59

7.6.1 Company Profile 59

7.6.2 Product Information 61

7.6.3 Revenue, Cost, Gross and Gross Margin 61

7.7 AstraZeneca 62

7.7.1 Company Profile 62

7.7.2 Product Information 63

7.7.3 Revenue, Cost, Gross and Gross Margin 63

7.8 Endo 64

7.8.1 Company Profile 64

7.8.2 Product Information 65

7.8.3 Revenue, Cost, Gross and Gross Margin 65

7.9 Merck 66

7.9.1 Company Profile 66

7.9.2 Product Information 67

7.9.3 Revenue, Cost, Gross and Gross Margin 67

7.10 Depomed 68

7.10.1 Company Profile 68

7.10.2 Product Information 69

7.10.3 Revenue, Cost, Gross and Gross Margin 69

7.11 Yunnan Baiyao 70

7.11.1 Company Profile 70

7.11.2 Product Information 71

7.11.3 Revenue, Cost, Gross and Gross Margin 72

7.12 Teva 72

7.12.1 Company Profile 72

7.12.2 Product Information 73

7.12.3 Revenue, Cost, Gross and Gross Margin 73

7.13 J&J 74

7.13.1 Company Profile 74

7.13.2 Product Information 75

7.13.3 Revenue, Cost, Gross and Gross Margin 76

7.14 Allergan 76

7.14.1 Company Profile 76

7.14.2 Product Information 77

7.14.3 Revenue, Cost, Gross and Gross Margin 77

7.15 Purdue 78

7.15.1 Company Profile 78

7.15.2 Product Information 79

7.15.3 Revenue, Cost, Gross and Gross Margin 79

8 Pain Management Drugs Manufacturing Cost Analysis 80

8.1 Pain Management Drugs R&D Cost Analysis 80

8.1.1 Clinical Phase Costs 81

8.1.2 Capitalized Costs 82

8.2 Proportion of Manufacturing Cost Structure 83

8.2.1 Raw Materials 83

8.2.2 Labor Cost 83

8.2.3 Manufacturing Expenses 90

8.3 Manufacturing Process Analysis of Pain Management Drugs 91

9 Industrial Chain, Sourcing Strategy and Downstream Buyers 92

9.1 Pain Management Drugs Industrial Chain Analysis 92

9.2 Upstream Raw Materials Sourcing 93

9.3 Downstream Buyers 93

10 Marketing Strategy Analysis, Distributors/Traders 97

10.1 Marketing Channel 97

10.1.1 Direct Marketing 97

10.1.2 Indirect Marketing 98

10.2 Market Positioning 98

10.2.1 Pricing Strategy 98

10.2.2 Brand Strategy 99

10.3 Distributors/Traders List 101

11 Market Effect Factors Analysis 102

11.1 Technology Progress/Risk 102

11.1.1 Substitutes Threat 102

11.1.2 Technology Progress in Related Industry 102

11.2 Consumer Needs/Customer Preference Change 108

11.3 Economic/Political Environmental Change 108

12 Global Pain Management Drugs Market Forecast (2017-2022) 120

12.1 Global Pain Management Drugs Revenue Forecast (2017-2022) 120

12.2 Global Pain Management Drugs Revenue Forecast by Regions (2017-2022) 120

12.2.1 North America Pain Management Drugs Revenue Forecast (2017-2022) 123

12.2.2 Europe Pain Management Drugs Revenue Forecast (2017-2022) 124

12.2.3 Asia-Pacific Pain Management Drugs Revenue Forecast (2017-2022) 125

12.2.4 South America Pain Management Drugs Revenue Forecast (2017-2022) 126

12.2.5 Middle East and Africa Pain Management Drugs Revenue Forecast (2017-2022) 127

12.3 Global Pain Management Drugs Consumption Forecast by Regions (2017-2022) 127

12.3.1 North America Pain Management Drugs Consumption Forecast (2017-2022) 130

12.3.2 Europe Pain Management Drugs Consumption Forecast (2017-2022) 131

12.3.3 Asia-Pacific Pain Management Drugs Consumption Forecast (2017-2022) 132

12.3.4 South America Pain Management Drugs Consumption Forecast (2017-2022) 133

12.3.5 Middle East and Africa Pain Management Drugs Consumption Forecast (2017-2022) 134

12.4 Global Pain Management Drugs Revenue Forecast by Types (2017-2022) 134

12.5 Global Pain Management Drugs Consumption Forecast by Application (2017-2022) 136

13 Research Findings and Conclusion 139

14 Methodology and Data Source 140

14.1 Methodology/Research Approach 140

14.1.1 Research Programs/Design 140

14.1.2 Market Size Estimation 141

14.1.3 Market Breakdown and Data Triangulation 142

14.2 Data Source 143

14.2.1 Secondary Sources 143

14.2.2 Primary Sources 144

14.3 Disclaimer 145

14.4 Author List 146

Figure Product Picture of Pain Management Drugs 1

Table Classification of Pain Management Drugs 2

Figure Global Pain Management Drugs Revenue Market Share by Types in 2016 3

Figure Opioids Examples 3

Figure NSAIDs Examples 4

Table Applications of Pain Management Drugs 4

Figure Global Pain Management Drugs Consumption Value Market Share by Applications in 2016 5

Figure Hospitals Examples 5

Figure Drugstores Examples 6

Figure Clinic Examples 6

Figure Global Pain Management Drugs Revenue (M USD) Comparison by Regions (2012-2022) 7

Figure North America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 8

Figure Europe Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 9

Figure Asia-Pacific Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 10

Figure South America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 11

Figure Middle East and Africa Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2022) 12

Figure Global Pain Management Drugs Revenue (M USD) Status and Outlook (2012-2022) 13

Table Global Pain Management Drugs Revenue (M USD) by Manufacturers (2016 and 2017) 14

Table Global Pain Management Drugs Revenue Market Share by Manufacturers (2016 and 2017) 14

Figure 2016 Global Pain Management Drugs Revenue Market Share by Manufacturers 16

Figure 2017 Global Pain Management Drugs Revenue Market Share by Manufacturers 17

Table Manufacturers Pain Management Drugs Headquarters and Established Date 17

Table Manufacturers Pain Management Drugs Product Category 18

Figure Pain Management Drugs Revenue Market Share in 2016 19

Figure Pain Management Drugs Revenue Market Share of Top 3 Manufacturers in 2016 20

Figure Pain Management Drugs Market Share of Top 5 Manufacturers in 2016 20

Table Mergers & Acquisitions, Expansion 21

Table Global Pain Management Drugs Revenue (M USD) by Regions (2012-2017) 27

Table Global Pain Management Drugs Revenue Market Share by Regions (2012-2017) 27

Figure Global Pain Management Drugs Revenue Market Share by Regions (2012-2017) 28

Figure 2012 Global Pain Management Drugs Revenue Market Share by Regions 28

Figure 2016 Global Pain Management Drugs Revenue Market Share by Regions 29

Table Global Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 29

Figure North America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 30

Table North America Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 30

Figure Europe Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 31

Table Europe Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 31

Figure Asia-Pacific Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 32

Table Asia-Pacific Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 32

Figure South America Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 33

Table South America Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 33

Figure Middle East and Africa Pain Management Drugs Revenue (M USD) and Growth Rate (2012-2017) 34

Table Middle East and Africa Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD) and Gross Margin (2012-2017) 34

Table Global Pain Management Drugs Consumption Value (M USD) Market by Regions (2012-2017) 35

Table Global Pain Management Drugs Consumption Market Share by Regions (2012-2017) 35

Figure Global Pain Management Drugs Consumption Market Share by Regions (2012-2017) 36

Figure 2012 Global Pain Management Drugs Consumption Market Share by Regions 36

Figure 2016 Global Pain Management Drugs Consumption Market Share by Regions 37

Figure North America Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 38

Figure Europe Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 39

Figure Asia-Pacific Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 40

Figure South America Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 41

Figure Middle East and Africa Pain Management Drugs Consumption Value (M USD) and Growth Rate (2012-2017) 42

Table Global Pain Management Drugs Revenue (M USD) by Types (2012-2017) 43

Table Global Pain Management Drugs Revenue Market Share by Types (2012-2017) 43

Figure Revenue Market Share of Pain Management Drugs by Types (2012-2017) 44

Figure 2012 Revenue Market Share of Pain Management Drugs by Types 44

Figure 2016 Revenue Market Share of Pain Management Drugs by Types 45

Figure Global Pain Management Drugs Revenue Growth Rate by Types (2012-2017) 45

Table Global Pain Management Drugs Consumption Value (M USD) by Applications (2012-2017) 46

Table Global Pain Management Drugs Consumption Market Share by Applications (2012-2017) 46

Figure Global Pain Management Drugs Consumption Market Share by Applications (2012-2017) 47

Figure Global Pain Management Drugs Consumption Market Share by Applications in 2012 47

Figure Global Pain Management Drugs Consumption Market Share by Applications in 2016 48

Figure Global Pain Management Drugs Consumption Growth Rate by Applications (2012-2017) 49

Table Pfizer Company Profile 50

Figure Pain Management Drugs Product Picture of Pfizer 51

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Pfizer 2016-2017 51

Table GSK Company Profile 52

Figure Pain Management Drugs Product Picture of GSK 53

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of GSK 2016-2017 54

Table Grunenthal Company Profile 54

Figure Pain Management Drugs Product Picture of Grunenthal 55

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Grunenthal 2016-2017 55

Table Bayer Company Profile 56

Figure Pain Management Drugs Product Picture of Bayer 57

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Bayer 2016-2017 57

Table Sanofi Company Profile 58

Figure Pain Management Drugs Product Picture of Sanofi 59

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sanofi 2016-2017 59

Table Eli Lilly Company Profile 59

Figure Pain Management Drugs Product Picture of Eli Lilly 61

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Eli Lilly 2016-2017 61

Table AstraZeneca Company Profile 62

Figure Pain Management Drugs Product Picture of AstraZeneca 63

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of AstraZeneca 2016-2017 63

Table Endo Company Profile 64

Figure Pain Management Drugs Product Picture of Endo 65

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Endo 2016-2017 65

Table Merck Company Profile 66

Figure Pain Management Drugs Product Picture of Merck 67

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Merck 2016-2017 67

Table Depomed Company Profile 68

Figure Pain Management Drugs Product Picture of Depomed 69

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Depomed 2016-2017 69

Table Yunnan Baiyao Company Profile 70

Figure Pain Management Drugs Product Picture of Yunnan Baiyao 71

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Yunnan Baiyao 2016-2017 72

Table Teva Company Profile 72

Figure Pain Management Drugs Product Picture of Teva 73

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Teva 2016-2017 73

Table J&J Company Profile 74

Figure Pain Management Drugs Product Picture of J&J 75

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of J&J 2016-2017 76

Table Allergan Company Profile 76

Figure Pain Management Drugs Product Picture of Allergan 77

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Allergan 2016-2017 77

Table Purdue Company Profile 78

Figure Pain Management Drugs Product Picture of Purdue 79

Table Pain Management Drugs Revenue (M USD), Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Purdue 2016-2017 79

Figure Typical Phases from Research to the Market for a Drug Candidate 81

Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 82

Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 83

Figure Manufacturing Cost Structure of Pain Management Drugs 83

Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 84

Figure Manufacturing Labor Costs in Select Provinces and Countries in 2016 85

Figure 2016 Global Manufacturing Competitiveness Index Rankings by Country 86

Figure US Nonfarm Unit Labor Cost 2014-2016 87

Figure United States Average Hourly Wages (USD/H) 2016-2017 87

Figure China Labor Cost Index 2014-2016 88

Figure China Average Yearly Wages 2006-2016 88

Figure Euro Area Labor Cost 2014-2016 89

Figure Japan Overview of Average Monthly Wages 2012-2017 (JPY Thousand/Month) 89

Figure 2016 Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%) 90

Table 2016 Global Electricity Price of Industry (USD/KW?h) by Country 90

Figure Manufacturing Process Analysis of Pain Management Drugs 91

Figure Pain Management Drugs Industrial Chain Analysis 92

Table Major Buyers of Pain Management Drugs 93

Figure Marketing Channel for Halal Pharmaceuticals 97

Figure Setting Pricing Policy 99

Table Distributors/Traders List 101

Figure Global GDP Growth Rate for 2016 109

Figure Malaysia GDP 2006-2016 (Billion USD) 110

Figure Brunei GDP 2006-2016 (Billion USD) 110

Figure Brazil GDP 2006-2016 (Billion USD) 111

Figure Brazil CPI Change 2016-2017 111

Figure Mexico GDP 2006-2016 (Billion USD) 112

Figure Mexico CPI Change 2012-2016 112

Figure USA GDP 2006-2016 (Billion USD) 113

Figure USA CPI Change 2016-2017 113

Figure EU GDP 2006-2016 (Billion USD) 114

Figure EU CPI Change 2012-2016 114

Figure Germany GDP 2006-2016 (Billion USD) 115

Figure UK GDP 2006-2016 (Billion USD) 115

Figure UK CPI Change 2016-2017 116

Figure Italy GDP 2006-2016 (Billion USD) 116

Figure Italy CPI Change 2016-2017 117

Figure Japan GDP 2006-2016 (Billion USD) 117

Figure Japan CPI Change 2012-2016 118

Figure China GDP 2006-2016 (Billion USD) 118

Figure China CPI Change 2016-2017 119

Figure Global Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 120

Table Global Pain Management Drugs Revenue (M USD) Forecast by Regions (2017-2022) 120

Table Global Pain Management Drugs Revenue Market Share Forecast by Regions (2017-2022) 121

Figure Global Pain Management Drugs Revenue Market Share Forecast by Regions (2017-2022) 121

Figure Global Pain Management Drugs Revenue Market Share Forecast by Regions in 2022 122

Figure North America Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 123

Figure Europe Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 124

Figure Asia-Pacific Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 125

Figure South America Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 126

Figure Middle East and Africa Pain Management Drugs Revenue (M USD) and Growth Rate Forecast (2017-2022) 127

Table Global Pain Management Drugs Consumption Value (M USD) Forecast by Regions (2017-2022) 127

Table Global Pain Management Drugs Consumption Market Share Forecast by Regions (2017-2022) 128

Figure Global Pain Management Drugs Consumption Market Share Forecast by Regions (2017-2022) 128

Figure Global Pain Management Drugs Consumption Market Share Forecast by Regions in 2022 129

Figure North America Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 130

Figure Europe Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 131

Figure Asia-Pacific Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 132

Figure South America Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 133

Figure Middle East and Africa Pain Management Drugs Consumption Value (M USD) and Growth Rate Forecast (2017-2022) 134

Table Global Pain Management Drugs Revenue (M USD) Forecast by Types (2017-2022) 134

Table Global Pain Management Drugs Revenue Market Share Forecast by Types (2017-2022) 135

Figure Global Pain Management Drugs Revenue Market Share Forecast by Types (2017-2022) 135

Figure Global Pain Management Drugs Revenue Market Share Forecast by Types in 2022 136

Table Global Pain Management Drugs Consumption Value (M USD) Forecast by Application (2017-2022) 136

Table Global Pain Management Drugs Consumption Forecast by Application (2017-2022) 136

Figure Global Pain Management Drugs Consumption Forecast by Application (2017-2022) 137

Figure Global Pain Management Drugs Consumption Forecast by Application in 2022 138

Table Research Programs/Design for This Report 140

Figure Bottom-up and Top-down Approaches for This Report 142

Figure Data Triangulation 143

Table Key Data Information from Secondary Sources 144

Table Key Data Information from Primary Sources 145